A method for removing compounds in the gaseous aggregate state from PLA-containing products in the viscous aggregate state by means of a thin-film evaporator. The compounds may be present in the liquid or solid aggregate state in the products under standard conditions. The invention further relates to a polylactide resin prepared in accordance with the method of the invention.

A method for removing compounds in the gaseous aggregate state from PLA-containing products in the viscous aggregate state by means of a thin-film evaporator. The compounds may be present in the liquid or solid aggregate state in the products under standard conditions. The invention further relates to a polylactide resin prepared in accordance with the method of the invention.

Method for making poly(propylene fumarate) (PPF) polymer made by ring-opening polymerization of propylene oxide and maleic anhydride in the presence of magnesium ethoxide initiator, wherein PPF is specifically designed for us in 3D manufacturing of medical devices. PPF polymers have a number average molecular weight (Mn) of from about 450 Daltons to about 3400 Daltons; a molecular mass distribution (m) of from 1.0 to 2.0; and contains less than 1% w/w of poly(maleic anhydride-co-propylene oxide) polymer chains particularly. PPF polymers are non-toxic, degradable, and resorbable and can be used in tissue scaffolds and medical devices that are implanted within a living organism.

Method for making poly(propylene fumarate) (PPF) polymer made by ring-opening polymerization of propylene oxide and maleic anhydride in the presence of magnesium ethoxide initiator, wherein PPF is specifically designed for us in 3D manufacturing of medical devices. PPF polymers have a number average molecular weight (Mn) of from about 450 Daltons to about 3400 Daltons; a molecular mass distribution (m) of from 1.0 to 2.0; and contains less than 1% w/w of poly(maleic anhydride-co-propylene oxide) polymer chains particularly. PPF polymers are non-toxic, degradable, and resorbable and can be used in tissue scaffolds and medical devices that are implanted within a living organism.

The present invention relates to an amphiphilic block copolymer composition which provides enhanced stability to a micelle formed by an amphiphilic block copolymer in an aqueous phase.

This disclosure provides a process for removing acrolein or allyl alcohol from a polyester composition, the process comprising: combining a polyester composition derived from 1,3-propanediol with an amino amide or a primary amine; wherein the amino amide or the primary amine is combined in sufficient quantities to scavenge acrolein or allyl alcohol produced from degradation of the polyester composition. An analysis of reactions between anthranilamide (AAA) and acrolein demonstrates how amines or amino amides can scavenge acrolein from thermally processed poly(trimethylene terephthalate) and poly(trimethylene furan-2,5-dicarboxylate), and thermodynamic models are presented as guidance for matching targets with scavenging agent.

This disclosure provides a process for removing acrolein or allyl alcohol from a polyester composition, the process comprising: combining a polyester composition derived from 1,3-propanediol with an amino amide or a primary amine; wherein the amino amide or the primary amine is combined in sufficient quantities to scavenge acrolein or allyl alcohol produced from degradation of the polyester composition. An analysis of reactions between anthranilamide (AAA) and acrolein demonstrates how amines or amino amides can scavenge acrolein from thermally processed poly(trimethylene terephthalate) and poly(trimethylene furan-2,5-dicarboxylate), and thermodynamic models are presented as guidance for matching targets with scavenging agent.

An object of the present invention is to provide a method for producing PHA, which is capable of suppressing the cost of overall production equipment including a waste water treatment process in production of PHA using microorganisms. Provided is a method including: a production step of purifying or molding polyhydroxyalkanoic acid biosynthesized in bacterial cells of a microorganism; a discharge step of discharging waste water containing nitrogen-containing impurities from the production step; and a nitrogen removal step of biologically treating the waste water to remove the nitrogen-containing impurities from the waste water. In the method, the residual ratio of the polyhydroxyalkanoic acid in the production step is 99% by weight or less, and the waste water that is biologically treated in the nitrogen removal step contains the polyhydroxyalkanoic acid in addition to the nitrogen-containing impurities.

An object of the present invention is to provide a method for producing PHA, which is capable of suppressing the cost of overall production equipment including a waste water treatment process in production of PHA using microorganisms. Provided is a method including: a production step of purifying or molding polyhydroxyalkanoic acid biosynthesized in bacterial cells of a microorganism; a discharge step of discharging waste water containing nitrogen-containing impurities from the production step; and a nitrogen removal step of biologically treating the waste water to remove the nitrogen-containing impurities from the waste water. In the method, the residual ratio of the polyhydroxyalkanoic acid in the production step is 99% by weight or less, and the waste water that is biologically treated in the nitrogen removal step contains the polyhydroxyalkanoic acid in addition to the nitrogen-containing impurities.

The present disclosure relates to a process for obtaining an ultrapure polymer by simply and effectively removing unreacted residual monomer in polymer, which is generated during production of a biodegradable polymer such as polylactic acid or derivatives thereof.